Even though Intuitive Surgical (NASDAQ: ISRG) considerably beat analyst estimates for both revenue and profitability for its Q3 of fiscal 2020, it wasn't enough to lift the stock late on Thursday.
The company, a top name in robotic surgical systems, released those figures after market close. They reveal that it booked revenue of just under $1.08 billion, down 4% on a year-over-year basis. Non-GAAP (adjusted) net income came in at $334 million ($2.77 per share) for the period, which was 18% down from the same quarter last year.
Image source: Getty Images.
Nevertheless, both headline numbers handily beat prognosticator estimates. On average, analysts tracking the stock anticipated just under $968 million on the top line and a per-share adjusted net profit of only $2.02.
While the coronavirus pandemic had a damaging effect on Intuitive Surgical's business earlier this year (the number of elective surgeries fell sharply when the outbreak spread), the company said it's recovering. It's not out of the woods yet, however -- its year-over-year declines were largely attributable to fewer placements and shipments of the Da Vinci line of robotic-surgery products, its main stock in trade.
Investor concern seemed to be with the company's uncertain future, as it didn't proffer any guidance. "Due to the continued uncertainty around the scope and duration of the pandemic and the timing of global recovery and economic normalization, we cannot, at this time, reliably estimate the future impact on our operations and financial results," it wrote in the results announcement.
This isn't sitting well with the market. In after-hours trading, Intuitive Surgical's shares are down by 3.6%. That's a steeper fall than that experienced by the S&P 500 index across the market's standard hours.
10 stocks we like better than Intuitive Surgical
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Intuitive Surgical wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of September 24, 2020
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Intuitive Surgical and recommends the following options: long January 2022 $580 calls on Intuitive Surgical and short January 2022 $600 calls on Intuitive Surgical. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.